SCHEMBL17147511

SCHEMBL17147511

COC(=O)c1cc(-c2ccco2)nc2nn(Cc3ccc(Cc4cc(C)c(C)c(C)c4)cc3)c(C)c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 1/20 0.46
▸ SLC2A2 P11168 1/20 0.46
▸ SLC2A3 P11169 1/20 0.46
▸ ALDH1A1 P00352 8/20 0.43
▸ HSD17B10 Q99714 6/20 0.43
▸ KDM4E B2RXH2 5/20 0.43
▸ USP2 O75604 4/20 0.43
▸ HPGD P15428 4/20 0.43
▸ TSHR P16473 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ MEN1 O00255 4/20 0.42
▸ POLB P06746 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ MCL1 Q07820 1/20 0.42
▸ BRCA1 P38398 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17147510 0.93 ALDH1A1 (0.51) SLC2A1SLC2A2SLC2A3ALDH1A1HSD17B10
SCHEMBL17147446 0.93 ALDH1A1 (0.47) SLC2A1SLC2A2SLC2A3ALDH1A1HSD17B10
SCHEMBL17147509 0.91 SLC2A1 (0.47) SLC2A1SLC2A2SLC2A3ALDH1A1HSD17B10
SCHEMBL17147474 0.90 SLC2A1 (0.45) SLC2A1SLC2A2SLC2A3ALDH1A1HSD17B10
SCHEMBL17147442 0.89 SLC2A1 (0.46) SLC2A1SLC2A2SLC2A3ALDH1A1HSD17B10
SCHEMBL17147455 0.89 ALDH1A1 (0.49) SLC2A1SLC2A2SLC2A3ALDH1A1HSD17B10
SCHEMBL17149352 0.89 UBE2I (0.50) SLC2A1SLC2A2SLC2A3ALDH1A1HSD17B10
SCHEMBL17147453 0.88 ALDH1A1 (0.47) SLC2A1SLC2A2SLC2A3ALDH1A1HSD17B10
SCHEMBL17147437 0.86 UBE2I (0.46) SLC2A1SLC2A2SLC2A3ALDH1A1HSD17B10
SCHEMBL17147433 0.86 SLC2A1 (0.44) SLC2A1SLC2A2SLC2A3ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150284387-A1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-10-08 — — US disclosed
US-20150284387-A1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-10-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284387-A1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF MCL1, BCL2L1, API5 SLC2A1 4576/4885SLC2A2 4698/4885SLC2A3 4682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback